Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,878 | 255 | 97.9% |
| Education | $84.72 | 8 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $926.74 | 81 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $503.48 | 28 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $216.12 | 7 | $0 (2022) |
| United Therapeutics Corporation | $203.76 | 8 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $159.20 | 11 | $0 (2020) |
| Gilead Sciences, Inc. | $153.32 | 13 | $0 (2021) |
| Genentech USA, Inc. | $139.52 | 12 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $129.43 | 10 | $0 (2018) |
| Medtronic USA, Inc. | $118.19 | 1 | $0 (2020) |
| Grifols USA, LLC | $115.70 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $372.42 | 29 | GlaxoSmithKline, LLC. ($148.64) |
| 2023 | $262.92 | 9 | Boehringer Ingelheim Pharmaceuticals, Inc. ($125.00) |
| 2022 | $172.10 | 9 | GlaxoSmithKline, LLC. ($86.23) |
| 2021 | $251.83 | 14 | JAZZ PHARMACEUTICALS INC. ($81.40) |
| 2020 | $430.78 | 22 | GlaxoSmithKline, LLC. ($192.18) |
| 2019 | $88.82 | 4 | Regeneron Healthcare Solutions, Inc. ($54.40) |
| 2018 | $670.35 | 48 | GlaxoSmithKline, LLC. ($112.21) |
| 2017 | $1,714 | 128 | GlaxoSmithKline, LLC. ($266.44) |
All Payment Transactions
263 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $8.72 | General |
| Category: Narcoplepsy | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.56 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $8.17 | General |
| Category: Narcoplepsy | ||||||
| 11/18/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $0.88 | General |
| Category: Narcoplepsy | ||||||
| 11/13/2024 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.78 | General |
| 10/22/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.65 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 07/31/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: IMMUNOLOGY | ||||||
| 06/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Immunology | ||||||
| 06/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: IMMUNOLOGY | ||||||
| 06/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: IMMUNOLOGY | ||||||
| 06/09/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: NEUROLOGY | ||||||
| 06/03/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.86 | General |
| Category: IMMUNOLOGY | ||||||
| 05/16/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: RESPIRATORY | ||||||
| 04/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $4.12 | General |
| Category: IMMUNOLOGY | ||||||
| 03/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $9.41 | General |
| Category: IMMUNOLOGY | ||||||
| 03/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 781 | 1,190 | $226,026 | $102,379 |
| 2022 | 15 | 565 | 948 | $199,568 | $90,624 |
| 2021 | 16 | 868 | 1,437 | $303,321 | $142,926 |
| 2020 | 15 | 901 | 1,502 | $341,292 | $166,001 |
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 128 | 223 | $75,820 | $36,096 | 47.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 187 | 352 | $45,760 | $21,303 | 46.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 106 | 175 | $28,050 | $15,919 | 56.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 53 | 77 | $15,708 | $6,950 | 44.2% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 15 | 41 | $6,560 | $4,786 | 73.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 27 | 27 | $7,342 | $3,576 | 48.7% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 15 | 43 | $5,664 | $3,013 | 53.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 30 | $6,600 | $2,898 | 43.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 20 | 21 | $3,990 | $1,830 | 45.9% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 16 | 16 | $8,480 | $1,604 | 18.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,310 | $1,385 | 60.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 22 | 22 | $2,090 | $860.86 | 41.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 18 | 18 | $1,710 | $647.58 | 37.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 14 | 14 | $2,450 | $393.82 | 16.1% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 13 | 13 | $1,183 | $308.99 | 26.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 24 | 24 | $2,280 | $220.08 | 9.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 25 | 25 | $2,375 | $169.50 | 7.1% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 27 | 27 | $4,185 | $168.48 | 4.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 19 | 19 | $3,325 | $148.96 | 4.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 12 | $144.00 | $100.80 | 70.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 102 | 224 | $76,160 | $38,331 | 50.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 164 | 339 | $69,156 | $26,418 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 122 | $19,570 | $11,241 | 57.4% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 23 | 63 | $8,190 | $4,397 | 53.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 21 | 22 | $4,840 | $2,217 | 45.8% |
About Dr. Winston Nara, MD
Dr. Winston Nara, MD is a Critical Care Medicine healthcare provider based in Greenwood, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114907607.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Winston Nara, MD has received a total of $3,963 in payments from pharmaceutical and medical device companies, with $372.42 received in 2024. These payments were reported across 263 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($3,878).
As a Medicare-enrolled provider, Nara has provided services to 3,115 Medicare beneficiaries, totaling 5,077 services with total Medicare billing of $501,929. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Sleep Medicine, Pulmonary Disease
- Location Greenwood, IN
- Active Since 01/19/2006
- Last Updated 01/14/2022
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1114907607
Products in Payments
- NUCALA (Biological) $497.44
- OFEV (Drug) $247.29
- ORENITRAM (Drug) $177.89
- BREO (Drug) $137.08
- ANORO (Drug) $132.98
- XOLAIR (Biological) $129.43
- ELIQUIS (Drug) $129.08
- TRELEGY ELLIPTA (Drug) $124.24
- Esbriet (Biological) $123.39
- Solitaire (Device) $118.19
- SUNOSI (Drug) $105.07
- OPSUMIT MACITENTAN (Drug) $101.11
- DUPIXENT (Biological) $100.65
- Prolastin-C (Biological) $64.07
- STIOLTO (Drug) $58.69
- UTIBRON (Drug) $57.53
- Hizentra (Biological) $57.39
- Utibron (Drug) $52.73
- INSPIRE (Device) $52.06
- Xyrem (Drug) $51.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Greenwood
Dr. Sandeep Kukreja, M.d, M.D
Critical Care Medicine — Payments: $358,561
Dr. Faisal Khan, Md, MD
Critical Care Medicine — Payments: $169,121
Dr. Imad Shawa, Md, MD
Critical Care Medicine — Payments: $28,103
Dr. Aaron Bruns, M.d, M.D
Critical Care Medicine — Payments: $4,727
Dr. Ruxandra Ionescu, Md, MD
Critical Care Medicine — Payments: $1,763
Melinda Quarles, Msn, Rn, MSN, RN
Critical Care Medicine — Payments: $368.07